| 1. | Alternation of plasma c - type natriuretic peptide in cerebral infarction
型利钠肽变化 |
| 2. | Brain natriuretic peptide , bnp
脑利钠肽 |
| 3. | Application and it ' s significance of the examination of plasma bnp in heart surgery
型利钠肽检测在心脏外科的应用及其意义 |
| 4. | Effect of ddd physiological pacing and vvi nonphysiological pacing on plasma natriuretic peptides level
生理性起搏与非生理性起搏对血浆心房利钠肽脑钠肽水平的影响 |
| 5. | The clinical study of plasma brain natriuretic peptide concentration and left ventricular hypertrophy in hypertension
血浆脑利钠肽浓度与高血压病左室肥厚及心功能的关系 |
| 6. | Diagnostic value of b type natriuretic peptide on diastolic heart failure in patients with 2 type diabetes mellitus
型利钠肽在2型糖尿病舒张性心功能不全患者诊断中的临床应用 |
| 7. | Intraenous atrial natriuretic peptide ( anp ) improes cardiac sympathetic nere actiity ( csna ) and preents left entricular ( l ) remodeling in patients with first anterior acute myocardial infarction ( ami ) , japanese researchers reeal
日本研究人员揭示，静脉内注射心房利钠肽（ anp ）可以改善心脏交感神经活性（ csna ）并预防首发前壁心肌梗死（ mi ）患者左室重塑。 |
| 8. | Patients with above - median mpo levels in combination with above - median plasma amino - terminal pro - brain natriuretic peptide ( nt - probnp ) or below - median left ventricular ejection fraction ( lvef ) had significantly greater mortality compared with other patients
在mpo中位数以上水平伴血浆氨基末端前脑利钠肽中位数水平以上病人或左心室射血分数在中位数以下病人相对于其他病人有更高的死亡率。 |
| 9. | Conclusion despite an initial reduction in plasma b - type natriuretic peptide level in patients in the levosimendan group compared with patients in the dobutamine group , levosimendan did not significantly reduce all - cause mortality at 180 days or affect any secondary clinical outcomes
结论：尽管和多巴酚丁胺组相比，左西孟旦组能降低病人初期血浆b型利钠肽水平，但是左西孟旦并不能显著地降低180天所有原因死亡率或其他任何次级观察结果。 |
